MonoGen Inc. Announces Facility Approval

LINCOLNSHIRE, ILLINOIS--(Marketwire - August 12, 2008) - MonoGen, Inc. (TSX: MOG) today announced that it has received FDA approval to distribute its products from its new manufacturing facility in Waukegan, Illinois. The company has been awaiting this approval since its relocation and subsequent PMA supplement, both of which occurred in 2007.
MORE ON THIS TOPIC